Kwality Pharmaceuticals Ltd

NSE: KPL · BSE: 539997 · Pharmaceuticals & Biotechnology · 21 announcements

Kwality Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹3,688.55
Market cap: ₹3,827 Cr
Revenue (annual): ₹503.1 Cr
Net profit (annual): ₹67.35 Cr
P/E (TTM): 47.2×Sector 47.4×
Promoter holding: 54.86%-0.01% QoQ
FII holding: 3.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 4 Financial Results 3 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Regulatory Approval 1 Debt & Borrowing 1 Credit Rating 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 12:10 IST BSE

Financial Results

Kwality Pharmaceuticals Q1 FY27 Results: Net Profit ₹25.6 Cr, Up 115.1% YoY

Kwality Pharmaceuticals Ltd reported revenue from operations of ₹162.4 Cr (+45.7% YoY) and net profit of ₹25.6 Cr (+115.1% YoY) for Q1 FY27.

Key figure: Net profit ₹25.6 Cr · +115.1% YoY

Open full results → Read the filing ↗

19 May 2026 11:50 IST BSE

Financial ResultsAlfa Alert

Kwality Pharmaceuticals Q4 FY26 Results: Net Profit ₹25.3 Cr, Up 74.5% YoY

Kwality Pharmaceuticals Ltd reported revenue from operations of ₹157.1 Cr (+35.8% YoY) and net profit of ₹25.3 Cr (+74.5% YoY) for Q4 FY26.

Key figure: Net profit ₹25.3 Cr · +74.5% YoY

Open full results → Read the filing ↗

19 May 2026 11:49 IST BSE

Financial Results

Kwality Pharmaceuticals Financial Results

Kwality Pharmaceuticals reported consolidated annual revenue of ₹503.08 Crore for FY26. Net profit stood at ₹67.35 Crore, reflecting strong operational growth and margin expansion.

Value: ₹503.1 Cr

Read the filing ↗